DRI Healthcare Trust (DHT.UN) Competitors C$14.12 +0.15 (+1.07%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock DHT.UN vs. ATT, AGRA, MJ, BIO, BBM, BAMM, LOVE, CSI, CALI, and DCNNShould you be buying DRI Healthcare Trust stock or one of its competitors? The main competitors of DRI Healthcare Trust include Abattis Bioceuticals (ATT), Agraflora Organics International (AGRA), Amplify Alternative Harvest ETF (MJ), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), BooksAMillion (BAMM), Cannara Biotech (LOVE), Chemesis International (CSI), China Auto Logistics (CALI), and Digicann Ventures (DCNN). These companies are all part of the "drug manufacturers - specialty & generic" industry. DRI Healthcare Trust vs. Its Competitors Abattis Bioceuticals Agraflora Organics International Amplify Alternative Harvest ETF Bio-Rad Laboratories Blueberries Medical BooksAMillion Cannara Biotech Chemesis International China Auto Logistics Digicann Ventures Abattis Bioceuticals (CNSX:ATT) and DRI Healthcare Trust (TSE:DHT.UN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings. Do analysts prefer ATT or DHT.UN? DRI Healthcare Trust has a consensus target price of C$19.50, indicating a potential upside of 38.10%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts clearly believe DRI Healthcare Trust is more favorable than Abattis Bioceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abattis Bioceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DRI Healthcare Trust 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ATT or DHT.UN more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Abattis Bioceuticals' net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Abattis Bioceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Abattis BioceuticalsN/A N/A N/A DRI Healthcare Trust 5.02%2.06%4.22% Do insiders & institutionals have more ownership in ATT or DHT.UN? 48.4% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable earnings and valuation, ATT or DHT.UN? DRI Healthcare Trust has higher revenue and earnings than Abattis Bioceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbattis BioceuticalsN/AN/AN/AN/AN/ADRI Healthcare TrustC$193.66MN/AC$9.73M-C$0.05-282.40 Does the media refer more to ATT or DHT.UN? In the previous week, Abattis Bioceuticals' average media sentiment score of 0.00 equaled DRI Healthcare Trust'saverage media sentiment score. Company Overall Sentiment Abattis Bioceuticals Neutral DRI Healthcare Trust Neutral SummaryDRI Healthcare Trust beats Abattis Bioceuticals on 9 of the 9 factors compared between the two stocks. Get DRI Healthcare Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHT.UN vs. The Competition Export to ExcelMetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapN/AC$2.13BC$5.48BC$6.20BDividend Yield3.26%2.92%4.73%6.72%P/E Ratio-282.404.2628.6763.43Price / SalesN/A677.30373.901,251.00Price / CashN/A10.3535.4583.29Price / Book1.5210.888.274.87Net IncomeC$9.73MC$21.15BC$3.24BC$301.20M7 Day Performance-3.62%0.05%-3.69%-2.26%1 Month Performance4.75%3.96%4.33%0.81%1 Year Performance21.83%2.20%25.95%26.63% DRI Healthcare Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHT.UNDRI Healthcare TrustN/AC$14.12+1.1%C$19.50+38.1%+20.6%C$0.00C$193.66M-282.40N/AHigh Trading VolumeATTAbattis BioceuticalsN/AN/AN/AN/AC$0.00N/A0.00N/AGap UpAGRAAgraflora Organics InternationalN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeMJAmplify Alternative Harvest ETFN/AN/AN/AN/A$0.00N/A0.007Gap UpBIOBio-Rad LaboratoriesN/AN/AN/AN/A$0.00N/A0.008,000High Trading VolumeBBMBlueberries MedicalN/AN/AN/AN/A$0.00N/A0.008High Trading VolumeBAMMBooksAMillionN/AN/AN/AN/A$0.00N/A0.00142High Trading VolumeLOVECannara BiotechN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeCSIChemesis InternationalN/AN/AN/AN/A$0.00N/A0.00147,000Gap DownHigh Trading VolumeCALIChina Auto LogisticsN/AN/AN/AN/A$0.00N/A0.0040Gap DownHigh Trading VolumeDCNNDigicann VenturesN/AN/AN/AN/A$0.00N/A0.00N/A Related Companies and Tools Related Companies Abattis Bioceuticals Competitors Agraflora Organics International Competitors Amplify Alternative Harvest ETF Competitors Bio-Rad Laboratories Competitors Blueberries Medical Competitors BooksAMillion Competitors Cannara Biotech Competitors Chemesis International Competitors China Auto Logistics Competitors Digicann Ventures Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:DHT.UN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DRI Healthcare Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share DRI Healthcare Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
